Collectively, our findings demonstrate that the WWOX/HIF1A ratio critically modulates oncogenic signalling across multiple tumour types, influencing prognosis, therapeutic response, and disease progression through the regulation of key proliferation and survival pathways. This evidence concerns the gene HIF1A and neoplasm.